AUPM855194A0 - Controlled-release pharmaceutical preparations - Google Patents

Controlled-release pharmaceutical preparations

Info

Publication number
AUPM855194A0
AUPM855194A0 AUPM8551A AUPM855194A AUPM855194A0 AU PM855194 A0 AUPM855194 A0 AU PM855194A0 AU PM8551 A AUPM8551 A AU PM8551A AU PM855194 A AUPM855194 A AU PM855194A AU PM855194 A0 AUPM855194 A0 AU PM855194A0
Authority
AU
Australia
Prior art keywords
controlled
pharmaceutical preparations
release pharmaceutical
release
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPM8551A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
Original Assignee
CSL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd filed Critical CSL Ltd
Priority to AUPM8551A priority Critical patent/AUPM855194A0/en
Publication of AUPM855194A0 publication Critical patent/AUPM855194A0/en
Priority to AU35999/95A priority patent/AU3599995A/en
Priority to PCT/AU1995/000648 priority patent/WO1996010395A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
AUPM8551A 1994-10-04 1994-10-04 Controlled-release pharmaceutical preparations Abandoned AUPM855194A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPM8551A AUPM855194A0 (en) 1994-10-04 1994-10-04 Controlled-release pharmaceutical preparations
AU35999/95A AU3599995A (en) 1994-10-04 1995-10-04 Controlled-release pharmaceutical preparations
PCT/AU1995/000648 WO1996010395A1 (en) 1994-10-04 1995-10-04 Controlled-release pharmaceutical preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM8551A AUPM855194A0 (en) 1994-10-04 1994-10-04 Controlled-release pharmaceutical preparations

Publications (1)

Publication Number Publication Date
AUPM855194A0 true AUPM855194A0 (en) 1994-10-27

Family

ID=3783070

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPM8551A Abandoned AUPM855194A0 (en) 1994-10-04 1994-10-04 Controlled-release pharmaceutical preparations

Country Status (2)

Country Link
AU (1) AUPM855194A0 (en)
WO (1) WO1996010395A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
DE19847252B4 (en) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Buccally applicable bioadhesive systems with time-controlled release of active ingredient containing testosterone esters and optionally additional testosterone
US6911204B2 (en) 2000-08-11 2005-06-28 Favrille, Inc. Method and composition for altering a B cell mediated pathology
GB0814953D0 (en) * 2008-08-18 2008-09-24 Unilever Plc Improvements relating to nanodisperse compositions
WO2010066203A1 (en) * 2008-12-10 2010-06-17 Anhui Zhongren Technology Co., Ltd. Controlled releasing composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337047C (en) * 1988-08-18 1995-09-19 Peter Dodd Cooper Gamma inulin compositions
US5219577A (en) * 1990-06-22 1993-06-15 The Regents Of The University Of California Biologically active composition having a nanocrystalline core
IT1243390B (en) * 1990-11-22 1994-06-10 Vectorpharma Int PHARMACEUTICAL COMPOSITIONS IN THE FORM OF PARTICLES SUITABLE FOR THE CONTROLLED RELEASE OF PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PROCEDURE FOR THEIR PREPARATION.
JP3583128B2 (en) * 1993-01-08 2004-10-27 シーエスエル、リミテッド Vaccine preparation

Also Published As

Publication number Publication date
WO1996010395A1 (en) 1996-04-11

Similar Documents

Publication Publication Date Title
IL139235A0 (en) Pharmaceutical preparations
AU7572196A (en) Pharmaceutical formulations
AU6995396A (en) Pharmaceutical formulation
AU3992697A (en) Pharmaceutical preparations for intranasal administration
IL131259A0 (en) Topical drug preparations
PL320856A1 (en) Aerosol drug preparations
AU3661695A (en) Pharmaceutical carriers
AU1566795A (en) Pharmaceutical ointment base
AU6973396A (en) Pharmaceutical formulation
AU6904896A (en) Pharmaceutical compounds
AU8072691A (en) Pharmaceutical preparations
AU4330097A (en) Pharmaceutical compounds
AU2531295A (en) Pharmaceutical composition
AU7582696A (en) Pharmaceutical formulation
GB9408053D0 (en) Pharmaceutical preparation
AU5280396A (en) Pharmaceutical microencapsulation
AUPM855194A0 (en) Controlled-release pharmaceutical preparations
AU4169897A (en) Pharmaceutical compounds
AU1475595A (en) Pharmaceutical preparation
EP0721784A4 (en) Controlled-release drug preparation
AU7711096A (en) Cisplatinum comprising pharmaceutical
AU1800100A (en) Medicinal preparations
AP9801196A0 (en) Pharmaceutical preparation
AU6236090A (en) Pharmaceutical preparations
PL308307A1 (en) 3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations